1
Study on Skin Toxicities Induced by Cancer Treatments
Condition(s):Solid Tumor, Adult; Breast Cancer; Lung Cancer; Digestive System Cancer; Ear Cancer; Nose Cancer; Throat CancerLast Updated:April 20, 2021Recruiting
Skin Toxicity: 2100 Clinical Trials, Page 1 of 210
Hide Studies Not Open or Pending
2
Skin Toxicity in Patients With Metastatic Colorectal Cancer Treated With Anti-EGFR and Chemotherapy (DERMIA)
Condition(s):Skin ToxicityLast Updated:April 8, 2020Completed
3
Panitumumab Skin Toxicity Prevention Trial
Condition(s):Colorectal Cancer Metastatic; Skin ToxicityLast Updated:March 4, 2020Recruiting
4
Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer
Condition(s):Ras-wildtype Colorectal CancerLast Updated:April 19, 2016Completed
5
SKIP – A Double-blind Placebo-controlled Randomized Multicenter Trial of Skin Toxicity Treatment
Condition(s):Colorectal CarcinomaLast Updated:July 14, 2014Terminated
6
Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy
Condition(s):Metastatic Colorectal Cancer; Skin Rash; Skin Toxicities; Colon Cancer; Colorectal CancerLast Updated:February 23, 2016Completed
7
Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment
Condition(s):Colorectal Cancer; Skin ToxicitiesLast Updated:June 27, 2011Unknown status
8
Phase II Study of Skin Toxicity Dosing of IRESSA (Gefitinib) in Squamous Cell Carcinoma of the Head and Neck
Condition(s):Head and Neck NeoplasmsLast Updated:July 1, 2016Completed
9
Pre-emptive Cycline Treatment on Cetuximab Induced Skin Toxicity in Colorectal Cancer
Condition(s):Colorectal Cancer Metastatic; Skin ToxicityLast Updated:March 25, 2020Terminated
10
Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation
Condition(s):Invasive Breast CancerLast Updated:October 3, 2019Completed